CW30175

General

Cell Line

hPSCreg Name
CIRMi867-A
Alternative name(s)
CW30175
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
CIRMi734-A
(CW30009)
Donor diseases:
Cardiomyopathy
CIRMi737-A
(CW30012)
Donor diseases:
Cardiomyopathy
CIRMi739-A
(CW30015)
Donor diseases:
Cardiomyopathy
CIRMi747-A
(CW30027)
Donor diseases:
Cardiomyopathy
CIRMi748-A
(CW30028)
Donor diseases:
Cardiomyopathy
CIRMi765-A
(CW30049)
Donor diseases:
Cardiomyopathy
CIRMi767-A
(CW30051)
Donor diseases:
Cardiomyopathy
CIRMi768-A
(CW30052)
Donor diseases:
Cardiomyopathy
CIRMi773-A
(CW30058)
Donor diseases:
Cardiomyopathy
CIRMi776-A
(CW30061)
Donor diseases:
Cardiomyopathy
CIRMi777-A
(CW30062)
Donor diseases:
Cardiomyopathy
CIRMi780-A
(CW30065)
Donor diseases:
Cardiomyopathy
CIRMi789-A
(CW30076)
Donor diseases:
Cardiomyopathy
CIRMi794-A
(CW30081)
Donor diseases:
Cardiomyopathy
CIRMi805-A
(CW30095)
Donor diseases:
Cardiomyopathy
CIRMi811-A
(CW30102)
Donor diseases:
Cardiomyopathy
CIRMi817-A
(CW30108)
Donor diseases:
Cardiomyopathy
CIRMi824-A
(CW30116)
Donor diseases:
Cardiomyopathy
CIRMi837-A
(CW30138)
Donor diseases:
Cardiomyopathy
CIRMi847-A
(CW30151)
Donor diseases:
Cardiomyopathy
CIRMi859-A
(CW30166)
Donor diseases:
Cardiomyopathy
CIRMi871-A
(CW30179)
Donor diseases:
Cardiomyopathy
CIRMi878-A
(CW30189)
Donor diseases:
Cardiomyopathy
CIRMi972-A
(CW30297)
Donor diseases:
Cardiomyopathy
CIRMi05U-A
(CW30520)
Donor diseases:
Cardiomyopathy
CIRMi733-A
(CW30008)
Donor diseases:
Cardiomyopathy
CIRMi730-A
(CW30005)
Donor diseases:
Cardiomyopathy
CIRMi732-A
(CW30007)
Donor diseases:
Cardiomyopathy
CIRMi740-A
(CW30016)
Donor diseases:
Cardiomyopathy
CIRMi745-A
(CW30022)
Donor diseases:
Cardiomyopathy
CIRMi753-A
(CW30033)
Donor diseases:
Cardiomyopathy
CIRMi759-A
(CW30042)
Donor diseases:
Cardiomyopathy
CIRMi772-A
(CW30056)
Donor diseases:
Cardiomyopathy
CIRMi775-A
(CW30060)
Donor diseases:
Cardiomyopathy
CIRMi825-A
(CW30119)
Donor diseases:
Cardiomyopathy
CIRMi830-A
(CW30126)
Donor diseases:
Cardiomyopathy
CIRMi839-A
(CW30140)
Donor diseases:
Cardiomyopathy
CIRMi845-A
(CW30148)
Donor diseases:
Cardiomyopathy
CIRMi873-A
(CW30181)
Donor diseases:
Cardiomyopathy
ISMMSi044-A
(PLNR14del-1BC1)
Donor diseases:
Cardiomyopathy
ISMMSi045-A
(PLNR14del-2BC4)
Donor diseases:
Cardiomyopathy
ISMMSi047-A
(PLN-R14del-4AC4)
Donor diseases:
Cardiomyopathy
ISMMSi048-A
(PLN-R14del-5BC4)
Donor diseases:
Cardiomyopathy
BRCi021-A
(TUH1)
Donor diseases:
Cardiomyopathy
UMCGi002-A
(CTP1-C1)
Donor diseases:
Cardiomyopathy
UMCGi002-B
(CTP1-C2)
Donor diseases:
Cardiomyopathy
UMCGi002-C
(CTP1-C3)
Donor diseases:
Cardiomyopathy
ISMMSi046-A
(PLN-R14del-3BC7)
Donor diseases:
Cardiomyopathy
UMCGi009-A
(PLN2-C2)
Donor diseases:
Cardiomyopathy
CIRMi886-A
(CW30197)
Donor diseases:
Dilated Cardiomyopathy
Last update 26th September 2023
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator California Institute for Regenerative Medicine (CIRM)
Owner California Institute for Regenerative Medicine (CIRM)
Distributors
Derivation country United States

External Databases

BioSamples SAMEA114427136
CLO CLO_0106012

General Information

* Is the cell line readily obtainable for third parties?
Yes
Research use: allowed
Clinical use: not allowed
Commercial use: allowed

Donor Information

General Donor Information

Sex male
Age of donor (at collection) 70-74

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
Cardiomyopathy
CARDIOMYOPATHY - OTHER
Synonyms
  • Cardiomyopathy
  • CARDIOMYOPATHY
  • Cardiomyopathy, NOS

External Databases (Donor)

BioSamples SAMEA114427137

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? No
Provide contact information of the holder of the original Donor Information Sheet: info@cirm.ca.gov
Do you (Depositor/Provider) hold the original Donor Consent Form? No
If you do not hold the Donor Consent Form, do you know who does? Yes
Contact information / weblink info@cirm.ca.gov
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Stanford University
Approval number eprotocol 27531
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Stanford University
Approval number eprotocol 27531
Is there an MTA available for the cell line? Yes

hIPSC Derivation

General

Source cell type
blood cell
A cell found predominately in the blood.
Age of donor (at collection) 70-74

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
No

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Essential 8™

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
POU5F1 (OCT-4)
Yes
NANOG
Yes
Lin28
Yes
Undifferentiated cells were analyzed by proprietary assays approved by California Institute of Regenerative Medicine (CIRM) as described in the attached publication. Pluripotency of established iPSC cultures were tested by qPCR on bulk samples using 48 genes including standard pluripotency genes (listed above). Samples were assigned a passing score after analysis with a non-supervised classifier based on an appropriate sample set. (Novak, T. 2015. Drug Discovery World pp. 47-53.)
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
Mesoderm
Ont Id: UBERON_0000926
Ectoderm
Ont Id: UBERON_0000924

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
Normal

Other Genotyping (Cell Line)